Articles published in Journal of Pharmacogenomics & Pharmacoproteomics have been cited by esteemed scholars and scientists all around the world. Journal of Pharmacogenomics & Pharmacoproteomics has got h-index 12, which means every article in Journal of Pharmacogenomics & Pharmacoproteomics has got 12 average citations.

Following are the list of articles that have cited the articles published in Journal of Pharmacogenomics & Pharmacoproteomics.

  2022 2021 2020 2019 2018

Year wise published articles

30 30 13 4 7

Year wise citations received

59 69 60 48 62
Journal total citations count 548
Journal Impact Factor 2.31
Journal 5 years Impact Factor 3.74
Journal CiteScore 4.86
Journal h-index 12
Important citations

Study of CYP3A5 genetic polymorphism in Vietnamese Kinh ethnic group

Interleukin 28B polymorphism as a predictor of response to treatment of Egyptian HCV patients working in nuclear material authority

Predictive value of IL-28B rs12979860 variants for peg-IFN, sofosbuvir plus ribavirin treatment of HCV infection in Pakistani population

Polymorphism in interferon ?3/interleukin-28B gene and risk to noncirrhotic chronic hepatitis C genotype 3 virus infection and its effect on the response to combined daclatasvir and sofosbuvir therapy

Resistance to Antimicrobial Agents: From Bacteria to Yeast

Phenotypic and Genotypic Characterization of Uropathogenic Escherichia Coli Isolates from Patients in Selected Hospitals in Kenya

Evaluation of antimicrobial activity of chondrillasterol isolated from Vernonia adoensis (Asteraceae)

The involvement of human organic anion transporting polypeptides (OATPs) in drug-herb/food interactions

Current insights toward kidney injury: Decrypting the dual role and mechanism involved of herbal drugs in inducing kidney injury and its treatment

Utilizing single- and double-transfected cell models expressing human organic anion transporter 1 and human cytochrome P450 1A2 to investigate the interactions with ingredients of herbal medicines

Identification of Potential Novel Inhibitors for Nipah Virus–An in silico Approach

Potential novel inhibitors against emerging zoonotic pathogen Nipah virus: a virtual screening and molecular dynamics approach

?????? ??????? ???????????? ????? CYP3A5

Consent for genetic biobanking in a diverse multisite CKD cohort

Racial disparities in family-provider interactions for pediatric asthma care

 Pharmacogenomics-Personalized treatment of cancer, diabetes and cardiovascular diseases

Receptory somatostatynowe w mózgu

Crosstalk and modulation of signaling between somatostatin and growth factor receptors in human breast cancer cell lines

Models of the urinary bladder

Signalling mechanisms